Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Digenic impairments of haploinsufficient genes in patients with craniosynostosis
Jung Woo Yu, Jihoon G. Yoon, Chaerim Han, Shin Hye Noh, Dong Min Shin, Yu-Mi Yang, Yong Oock Kim, Kyu-Won Shim, Min Goo Lee
Jung Woo Yu, Jihoon G. Yoon, Chaerim Han, Shin Hye Noh, Dong Min Shin, Yu-Mi Yang, Yong Oock Kim, Kyu-Won Shim, Min Goo Lee
View: Text | PDF
Research Article Bone biology Genetics

Digenic impairments of haploinsufficient genes in patients with craniosynostosis

  • Text
  • PDF
Abstract

Craniosynostosis (CRS) is characterized by the development of abnormal cranial suture ossification and premature fusion. Despite the identification of several associated genetic disorders, the genetic determinants of CRS remain poorly understood. In this study, we conducted integrative analyses on 225 exomes, comprising 121 CRS probands and 104 parental exomes (52 trios). These analyses encompassed de novo and pathogenic variants, and digenic combinations within haploinsufficient genes harboring rare variants. Our analysis unveils a shared molecular network between genes associated with CRS and those linked to skeletal and neurodevelopmental disorders, with a notable enrichment of deleterious variants within haploinsufficient genes. Additionally, we identified a unique digenic pair (IL6ST and TRPS1) within haploinsufficient genes that was present in 2 patients with nonsyndromic CRS but absent in parents or 1,048 population controls. In vitro experiments provided evidence that the identified missense variants were hypomorphs, and accelerated bone mineralization could result from the additive effects of diminished IL6ST and TRPS1 activities in osteoblasts. Overall, our study underscores the important role of rare variations in haploinsufficient genes and suggests that in a subset of undiagnosed patients, the CRS phenotype may arise from multiple genetic variations.

Authors

Jung Woo Yu, Jihoon G. Yoon, Chaerim Han, Shin Hye Noh, Dong Min Shin, Yu-Mi Yang, Yong Oock Kim, Kyu-Won Shim, Min Goo Lee

×

Figure 2

Identification of digenic combinations in haploinsufficient genes associated with CRS.

Options: View larger image (or click on image) Download as PowerPoint
Identification of digenic combinations in haploinsufficient genes associ...
(A) Investigation of rare digenic combinations in haploinsufficient genes (pLI > 0.9) associated with CRS. Rare deleterious variants, including LGD or D-mis) variants, were screened in 52 CRS trios. Digenic combinations observed in unaffected individuals were filtered using unaffected parents and population controls, with only those present exclusively in affected probands retained. The pathogenicity of case-specific digenic combinations was predicted using VarCoPP. Further analysis focused on digenic pairs falling within the 99.9% confidence zone of disease-causing variants and involved additional sequencing of 69 CRS probands. Through this approach, the TRPS1 and IL6ST gene pair was identified, observed in 2 independent undiagnosed cases. (B) Illustration of digenic interactions predicted by ORVAL in patient P093. Rare variants were filtered, and their pathogenicity was predicted based on gene-gene interaction networks, following the aforementioned process. (C) Prioritization of digenic combinations based on VarCoPP pathogenicity scores classified in the 99.9% zone. The validation cohort of 69 proband-only samples was then evaluated to identify additional undiagnosed cases harboring these digenic combinations.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts